Clinical Trials Results - National Cancer Institute

Skip to content

NCI Home

Cancer Topics

Clinical Trials

Cancer Statistics

Research & Funding

News

About NCI


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -7 of 7 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Randomized Study of Radiotherapy vs Radiotherapy plus Metronidazole as Radiosensitization in Patients with Advanced Gynecologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified				NCI				MSKCC-8082 NCI-T83-1374D, T83-1374

Last Modified: 11/1/2000


2.		Phase II Study of Antibiotics and Gastric Acid Inhibition for Gastric MALT Lymphoma (Summary Last Modified 11/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to 80				NCI				MDA-CPPDM-95084 NCI-T95-0003D, NCT00002682, T95-0003

Last Modified: 4/1/1999


3.		Phase II Trial of Antibiotic Eradication of Helicobacter Pylori and, Failing That, Local Therapy with Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) and Involved Field Radiation in Patients with Mucosa Associated Lymphoid Tissue (MALT) Lymphomas (Summary Last Modified 04/1999)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				SWOG-9703 S9703

Last Modified: 5/1/2000 First Published: 1/1/1998


4.		Phase II Study of Anti-Helicobacter pylori Treatment in Endoscopically Diagnosed Low Grade Localized Gastric Lymphoma (Summary Last Modified 05/2000)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								EORTC-20961 CRC-EORTC-20961, HOVON-33, NCT00003151

Last Modified: 5/3/2007


5.		Phase II Study of VP-16 plus Chemotherapy Resistance Modulators in the Treatment of VP-16-Resistant Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								CAN-OTT-9008 NCI-V91-0084


6.		Phase II Chemotherapy with Hycanthone Mesylate and Flagyl for Advanced Malignant Lymphomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified								MAYO-787801

Last Modified: 7/1/1997


7.		Radiotherapy Alone vs Radiotherapy plus Flagyl for Treatment of Brain Metastases (Summary Last Modified 07/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Treatment				Completed				no age specified				NCI				SWOG-7811

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute